5-HYDROXYTRYPTAMINE M-RECEPTOR ANTAGONISM TO PREVENT CISPLATIN-INDUCED EMESIS

被引：191

作者：

COSTALL, B

DOMENEY, AM

NAYLOR, RJ

TATTERSALL, FD

机构：

来源：

关键词：

D O I：

10.1016/0028-3908(86)90030-4

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：959 / 961

页数：3

共 10 条

[1] THE GASTROINTESTINAL-TRACT IN CHEMOTHERAPY-INDUCED EMESIS - A FINAL COMMON PATHWAY
AKWARI, OE
[J]. DRUGS, 1983, 25 : 18 - 34
[2] BUCHHEIT KH, 1985, J PHARM PHARMACOL, V37, P669
[3] COSTALL B, 1984, EUR J PHARMACOL, V102, P78
[4] FLORCZYK AP, 1982, CANCER TREAT REP, V66, P187
[5] FOZARD JR, 1982, BRIT J PHARMACOL, V77, pP520
[6] METOCLOPRAMIDE - A REVIEW OF ANTI-EMETIC TRIALS
GRALLA, RJ
[J]. DRUGS, 1983, 25 : 63 - 73
[7] NAUSEA AND VOMITING AS MAJOR COMPLICATIONS OF CANCER-CHEMOTHERAPY
LASZLO, J
[J]. DRUGS, 1983, 25 : 1 - 7
[8] MINER WD, 1986, BR J PHARM
[9] METOCLOPRAMIDE - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL USE
PINDER, RM
BROGDEN, RN
SAWYER, PR
SPEIGHT, TM
AVERY, GS
[J]. DRUGS, 1976, 12 (02) : 81 - 131
[10] IDENTIFICATION OF SEROTONIN M-RECEPTOR SUBTYPES AND THEIR SPECIFIC BLOCKADE BY A NEW CLASS OF DRUGS
RICHARDSON, BP
ENGEL, G
DONATSCH, P
STADLER, PA
[J]. NATURE, 1985, 316 (6024) : 126 - 131